Hematology Frontier

At the 50th Annual Meeting of the EBMT in Glasgow, Scotland, Florent Malard, MD, PhD, a Professor of Hematology at Sorbonne University and Saint-Antoine Hospital, Paris, France, provided critical insights…

On November 14, 2025, the Second International Cell and Immunotherapy Congress convened in Hangzhou. The meeting is co-chaired by He Huang from the First Affiliated Hospital of Zhejiang University School of Medicine and Mohamad Mohty, President of the International Academy for Clinical Hematology (IACH). Clinical experts, basic researchers, young scientists, and representatives from biopharmaceutical enterprises gathered from around the globe to engage in in-depth discussions on the latest advances in cell and immunotherapy. The congress not only showcased cutting-edge scientific achievements but also fostered meaningful interdisciplinary collaboration, illuminating key directions for future innovation in cell therapy, immunotherapy, and hematologic research. Oncology Frontier – Hematology Frontier Update has compiled highlights from the first day of the conference to share this academic event with colleagues and explore new frontiers in the field together.

Editor’s Note: From November 6 to 9, 2025, the China Conference on Holistic and Integrative Oncology (CCHIO 2025) was successfully held in Kunming. As one of the largest and most…

From November 6 to 9, 2025, the China Conference on Holistic and Integrative Oncology (CCHIO 2025) was successfully held in Kunming. As one of the largest and most influential oncology…

From November 6 to 9, 2025, the China Conference on Holistic and Integrative Oncology (CCHIO 2025) was successfully held in the spring city of Kunming. As one of the largest…

丨 2025 International Cell & Immunotherapy Congress** To promote innovation in China’s cell and immunotherapy fields, deepen scientific exchange, share the latest clinical research progress, and foster global collaboration and…

To promote innovation in China’s cell and immunotherapy landscape, facilitate in-depth exchange on key scientific questions, share the latest clinical research progress, and strengthen global collaboration and clinical translation, the 2025 International Cell & Immunotherapy Congress (CTI 2025)—jointly organized by Zhejiang University, the International Academy for Clinical Hematology (IACH), the Zhejiang Society of Immunology, and the Zhejiang Anti-Cancer Association, and co-hosted by the First Affiliated Hospital of Zhejiang University School of Medicine and the Liangzhu Laboratory—was held in Hangzhou from November 13 to 16, 2025.

To advance innovation in China’s cell therapy and immunotherapy landscape, deepen discussion on key scientific questions, share the latest clinical research progress, and promote global collaboration and clinical translation within the field, the 2025 International Cell and Immunotherapy Congress (CTI 2025) was held in Hangzhou, Zhejiang, from November 13 to 16, 2025. The congress was jointly organized by Zhejiang University, the International Academy for Clinical Hematology (IACH), the Zhejiang Society for Immunology, and the Zhejiang Anti-Cancer Association, and jointly hosted by the First Affiliated Hospital of Zhejiang University School of Medicine and the Liangzhu Laboratory.

The 67th American Society of Hematology (ASH) Annual Meeting will be held from December 6 to 9, 2025, in Orlando, USA. As one of the largest, most influential, and most comprehensive international congresses in hematology, ASH attracts tens of thousands of experts and scholars from around the world each year to share the latest advances and breakthrough research in the field.